Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.65 USD | +1.07% | +2.07% | +5.16% |
05-06 | Earnings Flash (CLDX) CELLDEX THERAPEUTICS Posts Q1 Revenue $156,000 | MT |
05-06 | Celldex Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.16% | 2.72B | |
+24.67% | 46.71B | |
+48.83% | 41.8B | |
-1.02% | 41.52B | |
-5.86% | 29.55B | |
+10.86% | 25.78B | |
-20.48% | 19.26B | |
+2.40% | 12.14B | |
-2.71% | 12.08B | |
+28.38% | 11.98B |
- Stock Market
- Equities
- CLDX Stock
- News Celldex Therapeutics, Inc.
- TD Cowen Initiates Celldex Therapeutics at Outperform Rating